Here's a look at what viewers found most interesting during the month of August on dicardiology.com

As we wind down the summer months, DAIC takes a look at the Top 10 most-read pieces of content from www.dicardiology.com during the month of August. 

August 30, 2023 — BIOFLOW-DAPT one-year-data demonstrated non-inferiority and a good safety profile for the Orsiro Missiondrug-eluting stent (DES) compared to Resolute Onyx DES (p<0.0001) in patients at high risk of bleeding receiving short 

August 30, 2023 — Immediate multivessel percutaneous coronary intervention (PCI) is non-inferior to staged multivessel PCI for reducing death and ischemic events in patients with 

August 30, 2023 — “Joining forces to protect the heart – this was our mission for this year’s ESC Congress,” said Professor Franz Weidinger, ESC President. “Cardiovascular (CV) medicine has been tremendously successful in improving and even prolonging life through paramount achievements over the last decades. Now it’s time to make sure that all of our patients who need treatment do get it – timely, effectively, sustainably. This is why we need to join forces as CV professionals, industry, policymakers, and patients.” 

August 29, 2023 — Optical coherence tomography (OCT) is non-inferior to intravascular ultrasound (IVUS) for guiding percutaneous coronary intervention (PCI), according

August 29, 2023 — The European Society of Cardiology (ESC) Guidelines on acute coronary syndromes are published online in European Heart Journal.1 The document covers the man

SCCT Global 2024 Budapest

August 28, 2023 — Is the routine implantation of an implantable cardioverter defibrillator (ICD) in myocardial infarction survivors with heart failure still an adequate therapy for prevention of sudden cardiac death? The PROFID EHRA trial is set to answer this question in a large, multicenter, EU-funded study set to enroll the first patient this summer.

August 28, 2023 — Ferric carboxymaltose(FCM) did not improve a hierarchical outcome of death, heart failure hospitalizations and exercise function in ambulatory patients with heart failure with reduced ejection fraction (HFrEF) and iron deficiency, according to late brea

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now